Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae

Retrovirology

Volumn 1, Issue , 2004, Pages

  Yao, Xiao Jian ^a,b   Rougeau, Nicole ^a   Duisit, Ghislaine ^a   Lemay, Julie ^a   Cohen, Éric A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; PEPTIDE; TRYPTOPHAN; VPR PROTEIN; PEPTIDE FRAGMENT; PRIMER DNA;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CONTROLLED STUDY; CYTOSTASIS; DATA ANALYSIS; FUNGAL CELL; GROWTH INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTAGENICITY; NONHUMAN; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; CELL DIVISION; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; VIROLOGY; VIRUS GENOME;

BASE SEQUENCE; CELL DIVISION; DNA PRIMERS; GENE PRODUCTS, VPR; GENOME, VIRAL; HIV-1; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SACCHAROMYCES CEREVISIAE; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 18144431033     PISSN: 17424690     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4690-1-21     Document Type: Article

References (58)

1. Cohen EA, Dehni G, Sodroski JG, Haseltine WA: Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 1990, 64:3097-3099.
2. Paxton W, Connor RI, Landau NR: Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational analysis. J Virol 1993, 67: 7229-7237.
3. Popov S, Rexach M, Zybarth G, Reiling N, Lee MA, Ratner L, Lane CM, Moore MS, Blobel G, Bukrinsky M: Viral protein R regulates nuclear import of HIV-1 pre-integration complex. EMBO J 1998, 17:909-917.
4. Vodicka MA, Koepp DM, Silver PA, Emerman M: HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 1998, 12:175-185.
5. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 1994, 91:7311-7315.
6. Yao XJ, Mouland AJ, Subbramanian RA, Forget J, Rougeau N, Bergeron D, Cohen EA: Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J Virol 1998, 72:4686-4693.
7. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M: HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 1998, 4:65-71.
8. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995, 69:6705-6711.
9. Re F, Braaten D, Franke EK, Luban J: Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995, 69:6859-6864.
10. Elder RT, Yu M, Chen M, Edelson S, Zhao Y: Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res 2000, 68:161-173.
11. Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y: HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology 2001, 287: 359-370.
12. Masuda M, Nagai Y, Oshima N, Tanaka K, Murakami H, Igarashi H, Okayama H: Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J Virol 2000, 74:2636-2646.
13. Zhao Y, Cao J, O'Gorman MR, Yu M, Yogev R: Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol 1996, 70:5821-5826.
14. Zhang C, Rasmussen C, Chang LJ: Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Virology 1997, 230:103-112.
15. Macreadie IG, Castelli LA, Hewish DR, Kirkpatrick A, Ward AC, Azad AA: A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci U S A 1995, 92: 2770-2774.
16. Gu J, Emerman M, Sandmeyer S: Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast. Mol Cell Biol 1997, 17:4033-4042.
17. Macreadie IG, Thorburn DR, Kirby DM, Castelli LA, de Rozario NL, Azad AA: HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae. FEBS Lett 1997, 410: 145-149.
18. Berglez JM, Castelli LA, Sankovich SA, Smith SC, Curtain CC, Macreadie IG: Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities. Biochem Biophys Res Commun 1999, 264:287-290.
19. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR: Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 1995, 69:7909-7916.
20. Forget J, Yao XJ, Mercier J, Cohen EA: Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. J Mol Biol 1998, 284:915-923.
21. Selig L, Benichou S, Rogel ME, Wu LI, Vodicka MA, Sire J, Benarous R, Emerman M: Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J Virol 1997, 71:4842-4846.
22. Chen M, Elder RT, Yu M, O'Gorman MG, Selig L, Benarous R, Yamamoto A, Zhao Y: Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 1999, 73:3236-3245.
23. Sawaya BE, Khalili K, Gordon J, Srinivasan A, Richardson M, Rappaport J, Amini S: Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73. J Virol 2000, 74:4877-4881.
24. Zhou Y, Ratner L: Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J Virol 2000, 74:6520-6527.
25. Mueller SM, Lang SM: The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest. J Virol 2002, 76:11704-11709.
26. Amon A, Surana U, Muroff I, Nasmyth K: Regulation of p34CDC28 tyrosine phosphorylation is not required for entry into mitosis in S. cerevisiae. Nature 1992, 355:368-371.
27. Sorger PK, Murray AW: S-phase feedback control in budding yeast independent of tyrosine phosphorylation of p34cdc28. Nature 1992, 355:365-368.
28. Piller SC, Ewart GD, Jans DA, Gage PW, Cox GB: The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J Virol 1999, 73: 4230-4238.
29. Stewart SA, Poon B, Jowett JB, Chen IS: Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol 1997, 71:5579-5592.
30. Macreadie IG, Arunagiri CK, Hewish DR, White JF, Azad AA: Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death. Mol Microbiol 1996, 19:1185-1192.
31. Zhao Y, Yu M, Chen M, Elder RT, Yamamoto A, Cao J: Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virology 1998, 246:266-276.
32. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G: The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000, 191:33-46.
33. Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillennec S, Hoebeke J, Rustin P, Metivier D, Lenoir C, Geuskens M, Vieira HL, Loeffler M, Belzacq AS, Briand JP, Zamzami N, Edelman L, Xie ZH, Reed JC, Roques BP, Kroemer G: Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med 2000, 193: 509-519.
34. Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB: Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun 2003, 304:583-592.
35. Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB: HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 2002, 277:37820-37831.
36. Patel CA, Mukhtar M, Pomerantz RJ: Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 2000, 74:9717-9726.
37. Stewart SA, Poon B, Song JY, Chen IS: Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol 2000, 74:3105-3111.
38. Yao X-J, Lemay J, Rougeau N, Clément M, Kurtzl S, Belhumeur P, Cohen EA: Genetic selection of inhibitory peptides against Human Immunodeficiency Virus Type 1 Vpr. J Biol Chem 2002, 277:48816-48826.
39. Wecker K, Morellet N, Bouaziz S, Roques BP: NMR structure of the HIV-1 regulatory protein Vpr in H20/trifluoroethanol. Comparison with the Vpr N-terminal (1-15) and C-terminal (52-96 domains). Eur J Biochem 2002, 269:3779-3788.
40. Yao X-J, Subbramanian RA, Rougeau N, Boisvert F, Bergeron D, Cohen EA: Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol 1995, 69:7032-7044.
41. Subbramanian RA, Yao XJ, Dilhuydy H, Rougeau N, Bergeron D, Robitaille Y, Cohen EA: Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J Mol Biol 1998, 278:13-30.
42. Wecker K, Roques BP: NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr. Eur J Biochem 1999, 266:359-369.
43. Schuler W, Wecker K, de Rocquigny H, Baudat Y, Sire J, Roques BP: NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J Mol Biol 1999, 285:2105-2117.
44. Singh SP, Tomkowicz B, Lai D, Cartas M, Mahalingam S, Kalyanaraman VS, Murali R, Srinivasan A: Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr. J Virol 2000, 74: 10650-10657.
45. Zhao LJ, Wang L, Mukherjee S, Narayan O: Biochemical mechanism of HIV-1 Vpr function: oligomerization mediated by the N-terminal domain. J Biol Chem 1994, 269:3231-3237.
46. Sherman MP, de Noronha CM, Heusch MI, Greene S, Greene WC: Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J Virol 2001, 75:1522-1532.
47. Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emaerman M, Sullivan JL, Stevenson M: Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A 2002, 99: 9503-9508.
48. Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen Z, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD: Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 2003, 111:1547-1554.
49. BouHamdan M, Xue Y, Baudat Y, Hu B, Sire J, Pomerantz RJ, Duan LX: Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J Biol Chem 1998, 273: 8009-8016.
50. BouHamdan M, Benichou S, Rev F, Navarro JM, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R, Sire J: Human immunodeficiency virus Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol 1996, 70:697-704.
51. Rogel ME, Wu LI, Emerman M: The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection. J Virol 1995, 69:882-888.
52. Piller SC, Jans P, Gage PW, Jans DA: Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci U S A 1998, 95:4595-4600.
53. Ferri KF, Jacotot E, Blanco J, Este JA, Kroemer G: Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann N Y Acad Sci 2000, 926:149-164.
54. Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N, Susin SA, Xie Z, Brothers G, Reed JC, Penninger JM, Kroemer G: Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 2000, 192: 1081-1092.
55. Roumier T, Vieira HL, Castedo M, Ferri KF, Boya P, Andreau K, Druillennec S, Joza N, Penninger JM, Roques B, Kroemer G: The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ 2002, 9:1212-1219.
56. Park HO, Chant J, Herskowitz I: BUD2 encodes a GTPase-activating protein for Bud1/Rsr1 necessary for proper bud-site selection in yeast. Nature 1993, 365:269-274.
57. Gietz D, St Jean A, Woods RA, Schiestl RH: Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 1992, 20:1425-1430.
58. Lavallée C, Yao X-J, Ladha A, Göttlinger H, Haseltine WA, Cohen EA: Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency type 1 viral particles. J Virol 1994, 68:1926-1934.